MedPath

A Randomised Control Trial of a Group Based Intervention and Relapse Prevention Package for Substance Misuse and Psychosis.

Not Applicable
Active, not recruiting
Conditions
Psychosis
Substance Use
Mental Health - Psychosis and personality disorders
Registration Number
ACTRN12610000249055
Lead Sponsor
Frameworks For health
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Active, not recruiting
Sex
All
Target Recruitment
120
Inclusion Criteria

Current Diagnosistic and Statistical Manual, Fourth Edition Revised (DSM-IV) diagnosis of schizophrenia or affective psychosis
Concurrent DSM-IV diagnosis of problematic substance use or dependence
Age 18yrs or over
Able to converse in English without an interpreter
Ability to engage in a one and a half hour group, with a mid-group break.

Exclusion Criteria

Age under 16 years
Unable to converse in English without an interpreter
Presence of developmental disability or amnestic syndrome that would impair ability to learn from the intervention.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Decreased substance dependence. The Opiate Treatment Index, the Alcohol Use Disorders Identification test (AUDIT), the Drug Abuse Screening Test (DAST), and the Severity of Substance Use are administered to all participants accross all time points.[3, 6, 9, 12 months and 5 years post intervention];Decreased impact of psychopathology. The World health organisation Quality of Life Questionnaire, the Life Skills profile, the Global Assessment of Functioning and the Brief Psychiatric Rating Scale are used for all participants.[3, 6, 9, 12 months and 5 years post intervention]
Secondary Outcome Measures
NameTimeMethod
Increased community service utilisation. the Diagnostic Interview for Psychosis: Service Utilisation (DIP-Part 3) is administered to all participants.[3, 6, 9, 12 months and 5 years post intervention]
© Copyright 2025. All Rights Reserved by MedPath